A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With Arthritis

NCT02727764 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Arthrogen

Collaborators